Cahill Wealth Management’s TransCode Therapeutics RNAZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Hold
0
-$22.9K 48
2022
Q4
Hold
0
47